Claims for Patent: 7,521,440

Summary for Patent: 7,521,440

Title:	Targeted oxidative therapeutic formulation
Abstract:	Pharmaceutical formulation, its method of preparation, and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to treat horses infected with Sarcocystis protozoal infections.
Inventor(s):	Hofmann; Robert F. (Austin, TX)
Assignee:	Torquin, LLC (Austin, TX)
Application Number:	11/074,192
Patent Claims:	1. A method for treating a protozoa-infected animal comprising: administering to the protozoa-infected animal an effective amount of a pharmaceutical formulation comprising: peroxidic species or reaction products resulting from oxidation of an isoprenoid by an oxygen-containing oxidizing agent, wherein the isoprenoid has less than about 35 carbons; a penetrating solvent; a dye containing a chelated divalent or trivalent metal; and an aromatic redox compound. 2. The method of claim 1, wherein the isoprenoid is in a liquid form, in a solution, or in dispersion. 3. The method of claim 1, wherein the isoprenoid comprises .A-inverted.-terpineol, citronellol, nerol, phytol, perillyl alcohol, menthol, or famesol. 4. The method of claim 1, wherein the isoprenoid comprises geraniol, geranylgeraniol, myricene, citrillene, citral, pinene, limonene, or linalool. 5. The method of claim 1, wherein the oxygen-containing oxidizing agent comprises singlet oxygen, oxygen in its triplet state, superoxide anion, periodate, hydroxyl radical, peroxide, or oxygen bound to a transition element. 6. The method of claim 1, wherein the oxygen-containing oxidizing agent comprises ozone. 7. The method of claim 1, wherein the penetrating solvent is a liquid, micelle membrane, emollient, plasma, or vapor. 8. The method of claim 1, wherein the penetrating solvent is dimethylsulfoxide. 9. The method of claim 1, wherein the penetrating solvent is polyvinylpyrrolidine or a pH-buffered saline. 10. The method of claim 1, wherein the penetrating solvent is aqueous solution, fats, sterols, lecithins, phosphatides, ethanol, propylene glycol, or methylsulfonylmethane. 11. The method of claim 1, wherein the dye comprises porphyrin or rose bengal. 12. The method of claim 1, wherein the dye comprises chiorophyllin, hemin, corrins, texaphrin, methylene blue, hematoxylin, eosin, erythrosin, lactoflavin, anthracene dye, hypericin, methyicholanthrene, neutral red, or fluorescein. 13. The method of claim 1, wherein the metal comprises iron. 14. The method of claim 1, wherein the metal comprises copper, manganese, tin, magnesium, or strontium. 15. The method of claim 1, wherein the aromatic redox compound comprises benzoquinone or naphthoquinone. 16. The method of claim 1 further comprising an electron donor. 17. The method of claim 16, wherein the electron donor comprises ascorbic acid or a pharmaceutical salt thereof. 18. The method of claim 16, wherein the electron donor comprises plasma, electrical current or germanium sesquioxide.

Details for Patent 7,521,440

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	07/20/1983		2021-03-30